cyc 202 has been researched along with zm 336372 in 3 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (zm 336372) | Trials (zm 336372) | Recent Studies (post-2010) (zm 336372) |
---|---|---|---|---|---|
979 | 7 | 393 | 27 | 0 | 11 |
Protein | Taxonomy | cyc 202 (IC50) | zm 336372 (IC50) |
---|---|---|---|
Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 100 | |
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.0603 | |
Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 0.57 | |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.23 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.18 | |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | 2 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.09 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
3 other study(ies) available for cyc 202 and zm 336372
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |